These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


212 related items for PubMed ID: 9310523

  • 1. Bone mineral density in prepubertal and in adolescent and young adult patients with the salt-wasting form of congenital adrenal hyperplasia.
    Gussinyé M, Carrascosa A, Potau N, Enrubia M, Vicens-Calvet E, Ibáñez L, Yeste D.
    Pediatrics; 1997 Oct; 100(4):671-4. PubMed ID: 9310523
    [Abstract] [Full Text] [Related]

  • 2. Bone mineral density and body composition in prepubertal and adolescent patients with the classical form of 21-hydroxylase deficiency.
    Sahakitrungruang T, Wacharasindhu S, Supornsilchai V, Srivuthana S, Kingpetch K.
    J Med Assoc Thai; 2008 May; 91(5):705-10. PubMed ID: 18672636
    [Abstract] [Full Text] [Related]

  • 3. Use of an aromatase inhibitor in children with congenital adrenal hyperplasia: Impact of anastrozole on bone mineral density and visceral adipose tissue.
    Halper A, Sanchez B, Hodges JS, Dengel DR, Petryk A, Sarafoglou K.
    Clin Endocrinol (Oxf); 2019 Jul; 91(1):124-130. PubMed ID: 31070802
    [Abstract] [Full Text] [Related]

  • 4. Effect of long-term glucocorticoid therapy on bone mineral density of the patients with congenital adrenal hyperplasia.
    Ünal S, Alikaşifoğlu A, Özön A, Gönç N, Kandemir N.
    Turk J Pediatr; 2020 Jul; 62(3):359-366. PubMed ID: 32558409
    [Abstract] [Full Text] [Related]

  • 5. Bone mineral density and body composition in congenital adrenal hyperplasia.
    Cameron FJ, Kaymakci B, Byrt EA, Ebeling PR, Warne GL, Wark JD.
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2238-43. PubMed ID: 7608286
    [Abstract] [Full Text] [Related]

  • 6. The effect of glucocorticoid replacement therapy on bone mineral density in children with congenital adrenal hyperplasia.
    Cetinkaya S, Kara C.
    J Pediatr Endocrinol Metab; 2011 Jul; 24(5-6):265-9. PubMed ID: 21823521
    [Abstract] [Full Text] [Related]

  • 7. Bone mineral density in girls with classical congenital adrenal hyperplasia due to CYP21 deficiency.
    Elnecave RH, Kopacek C, Rigatto M, Keller Brenner J, Sisson de Castro JA.
    J Pediatr Endocrinol Metab; 2008 Dec; 21(12):1155-62. PubMed ID: 19189689
    [Abstract] [Full Text] [Related]

  • 8. Correlation of Bone Mineral Parameters with Anthropometric Measurements and the Effect of Glucocorticoids on Bone Mineral Parameters in Congenital Adrenal Hyperplasia.
    Ganesh R, Suresh N, Janakiraman L, Ravikumar K.
    Indian J Pediatr; 2016 Feb; 83(2):126-30. PubMed ID: 26223873
    [Abstract] [Full Text] [Related]

  • 9. Bone mineral density and body composition in children with congenital adrenal hyperplasia.
    Halper A, Sanchez B, Hodges JS, Kelly AS, Dengel D, Nathan BM, Petryk A, Sarafoglou K.
    Clin Endocrinol (Oxf); 2018 Jun; 88(6):813-819. PubMed ID: 29460378
    [Abstract] [Full Text] [Related]

  • 10. Bone mineral density and fractures in congenital adrenal hyperplasia: Findings from the dsd-LIFE study.
    Riehl G, Reisch N, Roehle R, Claahsen van der Grinten H, Falhammar H, Quinkler M.
    Clin Endocrinol (Oxf); 2020 Apr; 92(4):284-294. PubMed ID: 31886890
    [Abstract] [Full Text] [Related]

  • 11. The relation of peripubertal and pubertal growth to final adult height in children with classic congenital adrenal hyperplasia.
    Bomberg EM, Addo OY, Kyllo J, Gonzalez-Bolanos MT, Ltief AM, Pittock S, Himes JH, Miller BS, Sarafoglou K.
    J Pediatr; 2015 Mar; 166(3):743-50. PubMed ID: 25557963
    [Abstract] [Full Text] [Related]

  • 12. Real-world impact of glucocorticoid replacement therapy on bone mineral density: retrospective experience of a large single-center CAH cohort spanning 24 years.
    Iervolino LL, Ferraz-de-Souza B, Martin RM, Costa FC, Miranda MC, Mendonça BB, Bachega TS.
    Osteoporos Int; 2020 May; 31(5):905-912. PubMed ID: 31897546
    [Abstract] [Full Text] [Related]

  • 13. Height, bone mineral density and bone markers in congenital adrenal hyperplasia.
    Paganini C, Radetti G, Livieri C, Braga V, Migliavacca D, Adami S.
    Horm Res; 2000 May; 54(4):164-8. PubMed ID: 11416232
    [Abstract] [Full Text] [Related]

  • 14. Bone Mass in Young Patients with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency.
    Espinosa Reyes TM, Leyva González G, Domínguez Alonso E, Falhammar H.
    Horm Res Paediatr; 2021 May; 94(1-2):1-8. PubMed ID: 34044395
    [Abstract] [Full Text] [Related]

  • 15. [Estimation of influence of congenital-adrenal hyperplasia treatment on bone mineralisation evaluated with densitometry].
    Romanowska H, Krzywińska-Zdeb E, Giżewska M, Kotkowiak L, Safranow K, Horodnicka-Józwa A, Petriczko E, Krupa B, Walczak M.
    Pediatr Endocrinol Diabetes Metab; 2012 May; 18(1):21-6. PubMed ID: 22525687
    [Abstract] [Full Text] [Related]

  • 16. Bone turnover and bone mineral density in patients with congenital adrenal hyperplasia.
    Guo CY, Weetman AP, Eastell R.
    Clin Endocrinol (Oxf); 1996 Nov; 45(5):535-41. PubMed ID: 8977749
    [Abstract] [Full Text] [Related]

  • 17. Bone mineral density is not significantly reduced in adult patients on low-dose glucocorticoid replacement therapy.
    Koetz KR, Ventz M, Diederich S, Quinkler M.
    J Clin Endocrinol Metab; 2012 Jan; 97(1):85-92. PubMed ID: 21994966
    [Abstract] [Full Text] [Related]

  • 18. Bone mineral density, bone markers, and fractures in adult males with congenital adrenal hyperplasia.
    Falhammar H, Filipsson Nyström H, Wedell A, Brismar K, Thorén M.
    Eur J Endocrinol; 2013 Mar; 168(3):331-41. PubMed ID: 23211577
    [Abstract] [Full Text] [Related]

  • 19. Early growth, pubertal development, body mass index and final height of patients with congenital adrenal hyperplasia: factors influencing the outcome.
    Manoli I, Kanaka-Gantenbein Ch, Voutetakis A, Maniati-Christidi M, Dacou-Voutetakis C.
    Clin Endocrinol (Oxf); 2002 Nov; 57(5):669-76. PubMed ID: 12390343
    [Abstract] [Full Text] [Related]

  • 20. Long-term follow-up of children with classic congenital adrenal hyperplasia: suggestions for age dependent treatment in childhood and puberty.
    Pijnenburg-Kleizen KJ, Thomas CMG, Otten BJ, Roeleveld N, Claahsen-van der Grinten HL.
    J Pediatr Endocrinol Metab; 2019 Oct 25; 32(10):1055-1063. PubMed ID: 31573958
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.